EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review

Elena Silverstein, Michael Richmann, Delaney Tyl, Ashley Fiaoni, Kylie Pfeifer, Hadi Moussa, Alysia Treacy, Mathew Vigliotta, Michael Schepps, Reena Sheth, Patrick Barry

Cureus · 27.11.2024

DOI: 10.7759/cureus.74611 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Cureus, erschienen am 27.11.2024. Verfasst von Elena Silverstein und 10 weiteren Autor:innen. Beteiligte Einrichtung: Foundational Sciences, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis (PF) is a medical condition that affects the lungs and causes scarring due to the deposition of excess fibrotic tissue. This is often preceded by various causes and can lead to long-term health consequences. The treatment of PF using mesenchymal stem cells (MSCs) to correct lung damage and decrease inflammation is a current focus of research. MSCs are beneficial in inhibiting the immune response and inducing more efficient repair processes, therefore having the potential to be useful in various settings. This review aims to identify the current utilization of MSCs in treating PF in adults. A systematic search was conducted according to the Joanna Briggs Institute Reviewers Manual using Ovid Medline, Embase, and Web of Science to identify studies. Following PRISMA guidelines, eligible peer-reviewed studies that used MSCs to treat adults with PF were identified. The initial search produced 1,836 articles after removing duplicates. Twenty-nine articles met the inclusion criteria. A final analysis of the articles further narrowed the number to eight articles that met all criteria and were relevant to the scoping review's objective. Four studies utilized bone marrow-derived MSCs, two utilized umbilical-derived MSCs, one utilized placenta-derived MSCs, and one utilized adipose-derived MSCs. Of these studies, five administered treatments via an intravenous infusion, two used an endobronchial infusion, and the last utilized an intratracheal approach. The use of MSCs in the treatment of PF in adults was found to be safe with the most common adverse effect reported being fever and chills which resolved a few hours after administration. Although the research regarding MSC use in the treatment of idiopathic PF is relatively new, our results summarize the current sources, route of administration, and current adverse effects. We have shown that future studies with larger sample sizes should be performed to determine long-term outcomes and overall efficacy before clinical practice guidelines become implemented.

Schlagwörter

Stichwörter der Autor:innen

ards (acute respiratory distress syndrome)autologus stem cell transplantcovid 19lung diseasemesenchymal stem cellspulmonary fibrosis

Autor:innen und Institutionen

  • Foundational Sciences, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.
  • Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.

Zitieren

APA

Silverstein, E., Richmann, M., Tyl, D., Fiaoni, A., Pfeifer, K., Moussa, H., Treacy, A., Vigliotta, M., Schepps, M., Sheth, R., & Barry, P. (2024). The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review. Cureus. https://doi.org/10.7759/cureus.74611

Vancouver

Silverstein E, Richmann M, Tyl D, Fiaoni A, Pfeifer K, Moussa H, et al. The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review. Cureus. 2024. doi:10.7759/cureus.74611

BibTeX
@article{Silverstein2024,
  author = {Silverstein, Elena and Richmann, Michael and Tyl, Delaney and Fiaoni, Ashley and Pfeifer, Kylie and Moussa, Hadi and Treacy, Alysia and Vigliotta, Mathew and Schepps, Michael and Sheth, Reena and Barry, Patrick},
  title = {The Application of Mesenchymal Stem Cell Therapy in Treating Pulmonary Fibrosis: A Scoping Review},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.74611}
}
Kostenlos starten →